← Eichor
Study identifier: NCT05765864 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Self-harm Behaviour Among the Most At-risk Adolescents

Condition: Self-harm · Personality Disorder, Borderline · Epigenetic Disorder  ·  Sponsor: University of Ljubljana, Faculty of Medicine

PhaseN/A
Planned participants400
Who can joinAll sexes, 13 Years to 18 Years
Healthy volunteersYes

About this study

In the proposed study, three objectives will be pursued: 1. To develop a method to identify more effectively the acute and long-term risk of adolescents with the most threatening self-harm behaviours. 2. To identify the factors that influence the risk of self-harm behaviours and the success of treatment/treatment of these behaviours in the most at-risk adolescents (changes in these factors). 3. Develop guidelines for more effective treatment of the most at-risk adolescents. For this purpose, a sample of approximately 200 young people who will be hospitalised for suicide risk (the most at risk in Slovenia) and an approximately equal number of healthy adolescents will be included. At inclusion, the presence of several factors will be assessed by reviewing demographic data, clinical diagnosis, self-assessment questionnaires and clinical psychological tests (CSSRS, B-NSSI-AT, ISAS, LPFS-BF2.0, BPFSC-11, TSCC, PAI, ECR-RS, DASA-YV, ASHRS), social assessment, and blood sampling for genetic analyses (DNA isolation, sequencing, nucleotide sequence recognition, quantification and evaluation of short tandem repeats, identification of methylation sites). Longitudinal tracking of autoaggressive events and heteroaggressive events during hospitalisation will be performed and recorded on an ongoing basis. The risk and protective factors of the adolescents most at risk will be compared with a control group of adolescents. The same factors will be reassessed in the most at-risk adolescents …

This description comes directly from the study's public registry record.

Talk to the study team

Maja Drobnič Radobuljac  ·  015874840  ·  maja.radobuljac@psih-klinika.si

Maja Drobnič Radobuljac  ·  maja.radobuljac@psih-klinika.si

Always discuss trial participation with your own doctor first.

Locations (2)

Medical Faculty - University of LjubljanaLjubljana, SloveniaActive Not Recruiting
University Psychiatric Clinic LjubljanaLjubljana, SloveniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05765864